•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. (NASDAQ: AQST) and is reminding investors of a May 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company.
According to the complaint, Aquestive and its executives allegedly violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of the company’s NDA for Anaphylm.
The complaint further alleges that the company concealed or minimized the significance of human factors in using its sublingual film, including packaging, use, administration, and labeling.
On January 9, 2026, the company’s CEO announced that, as part of the NDA review, the FDA identified deficiencies that preclude discussion of labeling and post-marketing commitments at that time.
Aquestive disclosed that the notification did not specify the deficiencies.
Trading activity reflected the news, with the stock closing down 37.04% at $3.91 on January 9, 2026.
The court-appointed lead plaintiff will be the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members.
Any member of the putative class may move the court to serve as lead plaintiff through counsel or may remain an absent class member.
The statement also clarifies that participation in potential recovery is not contingent on serving as lead plaintiff.
Faruqi & Faruqi invites anyone with information regarding Aquestive’s conduct to contact the firm. For more information about the Aquestive Therapeutics class action, the firm directs readers to www.faruqilaw.com/AQST or to call Josh Wilson at 877-247-4292.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
